Telangana High Court Grants Medicover Interim Relief as ₹13,200-Crore KKR Deal Triggers Political Row; BRS Seeks ED Probe

A proposed ₹13,200-crore acquisition of Medicover Hospitals India by global investment firm KKR has triggered a political controversy in Telangana, with the opposition Bharat Rashtra Samithi (BRS) demanding an Enforcement Directorate (ED) investigation into alleged business interests linked to the family of Chief Minister A. Revanth Reddy. The controversy has now taken a legal turn, with the Telangana High Court granting Medicover Hospitals interim protection against defamatory publications.

On October 16, the Telangana High Court restrained the respondents, including BRS spokesperson Manne Krishank, Harish Reddy, Shankar Goud, and the concerned media organisations and intermediaries, from publishing content defamatory of Medicover Hospitals. The court observed that the publications under consideration prima facie met the test of defamation and contained injurious and derogatory descriptions that could damage the hospital’s reputation, create anxiety among existing patients and deter prospective patients from seeking treatment. The interim order will remain in force until the respondents present their case or until further orders.

The court’s interim order concerns publications about Medicover Hospitals and does not, by itself, establish the truth or falsity of every political allegation concerning the wider transaction or individuals allegedly connected to the Chief Minister’s family.

What triggered the controversy?

On October 3, BRS leader Manne Krishank called for an ED probe into the ₹13,200-crore transaction and demanded scrutiny of the ownership structures, shareholdings, investments and financial transactions of companies allegedly linked to individuals connected with the Chief Minister’s family.

Krishank also alleged that the family’s business interests exceeded ₹50,000 crore. This figure has not been independently established, and the allegations remain unproven.

The opposition has questioned whether minority investors in Medicover’s Indian hospital business have undisclosed connections to the Chief Minister’s family. It has also called for an examination of the source of investment funds and the ultimate beneficiaries of the proposed transaction.

Understanding the ₹13,200-crore deal

Swedish healthcare group Medicover AB announced on August 6 that it had agreed to sell its Indian hospital business to funds managed by KKR. The transaction values the business at €1.2 billion, with Medicover expecting gross cash proceeds of €740 million.

Medicover held a 66.1% stake in the business, while minority partners held the remaining 33.9%. The transaction was subject to regulatory approvals and was expected to close in the fourth quarter of 2026.

The transaction’s overall valuation does not establish that the proceeds belong to the Chief Minister or his family. Any such connection would require evidence from shareholding records, investment agreements and financial disclosures.

Corporate links under scrutiny

The allegations partly concern Maxbien Pharma and Sahrudaya Health Care Private Limited, the corporate entity associated with Medicover’s Indian hospital operations.

Corporate records cited in public reporting identify Goluguri Satyanarayana Reddy, described as the Chief Minister’s son-in-law, among Maxbien Pharma’s directors. Dumpa Sirisha and Annam Sharath have also held directorships in the company. Annam Sharath has reportedly been associated with Sahrudaya Healthcare.

The BRS has alleged that Dumpa Sirisha holds interests in Sahrudaya Healthcare on behalf of the Chief Minister’s family. It has also raised questions about her reported links to MindVault, an education venture the opposition associates with Revanth Reddy’s daughter, Naimisha Reddy.

These claims have not been independently substantiated. Directorships and commercial associations alone do not establish beneficial ownership or prove that someone holds assets on another person’s behalf.

The opposition has also raised questions about a ₹1,000-crore investment announcement involving Swachh Bio, a land allotment to Tesseract Advanced Systems, and contracts involving Shodha Constructions and KLSR Infratech. The Telangana government has rejected allegations of favouritism concerning the Tesseract allotment, while Shodha Constructions has denied wrongdoing.

Political row and arrests

The controversy escalated after banners referring to the Medicover transaction appeared outside its Secunderabad hospital on October 4, leading to the arrest of two BRS activists.

Krishank was arrested on October 6 in a separate case involving allegedly defamatory statements about the Chief Minister’s daughter and was subsequently released on bail.

On October 9, Medicover COO Mahesh Degloorkar said politicians from different parties had attended hospital inaugurations in their official capacities, cautioning against inferring political affiliations from such appearances.

Medicover has also emphasised the importance of factual accuracy and responsible public discourse, stating that publications concerning healthcare institutions can affect patients’ confidence and decisions about medical care.

What remains to be established?

The key questions are whether documentary evidence establishes any undisclosed beneficial ownership, whether the source of investment funds warrants further scrutiny, and whether any government decisions improperly benefited businesses connected to individuals close to the Chief Minister.

These questions would require examination of shareholding disclosures, investment agreements, financial records and relevant government decisions. The BRS’s demand for an ED investigation does not itself establish wrongdoing, just as the transaction’s valuation alone does not prove that the Chief Minister or his family received any financial benefit.

The High Court’s interim protection for Medicover is a significant legal development in the controversy, particularly regarding publications that the court found prima facie defamatory. However, the order should not be treated as a blanket determination of every allegation surrounding the wider business transaction.

For now, the allegations of undisclosed family interests remain unproven. Any conclusions about conflicts of interest, financial impropriety or misuse of public office would depend on verifiable evidence and the findings of any competent investigation.

Also Read: 3 Men Booked Under Arms Act in Chandigarh’s Attawa; FIR Registered